{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "Virucidal activity",
      "Visible light responsive photocatalyst"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34092715",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "06",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.4265/bio.26.119"
    ],
    "Journal": {
      "ISSN": "1884-0205",
      "JournalIssue": {
        "Volume": "26",
        "Issue": "2",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Biocontrol science",
      "ISOAbbreviation": "Biocontrol Sci"
    },
    "ArticleTitle": "Effect of the Photocatalyst under Visible Light Irradiation in SARS-CoV-2 Stability on an Abiotic Surface.",
    "Pagination": {
      "StartPage": "119",
      "EndPage": "125",
      "MedlinePgn": "119-125"
    },
    "Abstract": {
      "AbstractText": [
        "There is a worldwide attempt to develop prevention strategies against SARS-CoV-2 transmission. Here we examined the effectiveness of tungsten trioxide (WO<sub>3</sub>)-based visible light-responsive photocatalyst on the inactivation of SARS-CoV-2 under different temperatures and exposure durations. The viral titer on the photocatalyst-coated glass slides decreased from 5.93 \u00b1 0.38 logTCID<sub>50</sub> /mL to 3.05 \u00b1. 25 logTCID<sub>50</sub>/mL after exposure to 3,000 lux of the visible light irradiation for 6h at 20\u2103. On the other hand, lighting without the photocatalyst, or the photocatalyst-coat without lighting retained viral stability. Immunoblotting and electron microscopic analyses showed the reduced amounts of spike protein on the viral surface after the photocatalyst treatment. Our data suggest a possible implication of the photocatalyst on the decontamination of SARS-CoV-2 in indoor environments, thereby preventing indirect viral spread."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Biomedical Food Research, National Institute of Health Sciences."
          }
        ],
        "LastName": "Uema",
        "ForeName": "Masashi",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Biomedical Food Research, National Institute of Health Sciences."
          }
        ],
        "LastName": "Yonemitsu",
        "ForeName": "Kenzo",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Biomedical Food Research, National Institute of Health Sciences."
          }
        ],
        "LastName": "Momose",
        "ForeName": "Yoshika",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Infectious Diseases, Toho University School of Medicine."
          }
        ],
        "LastName": "Ishii",
        "ForeName": "Yoshikazu",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Infectious Diseases, Toho University School of Medicine."
          }
        ],
        "LastName": "Tateda",
        "ForeName": "Kazuhiro",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences."
          }
        ],
        "LastName": "Inoue",
        "ForeName": "Takao",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Biomedical Food Research, National Institute of Health Sciences."
          }
        ],
        "LastName": "Asakura",
        "ForeName": "Hiroshi",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Japan",
    "MedlineTA": "Biocontrol Sci",
    "NlmUniqueID": "9712121",
    "ISSNLinking": "1342-4815"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Oxides"
    },
    {
      "RegistryNumber": "V9306CXO6G",
      "NameOfSubstance": "Tungsten"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "transmission"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "radiation effects"
      ],
      "DescriptorName": "Catalysis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Light"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Oxides"
    },
    {
      "QualifierName": [
        "growth & development",
        "pathogenicity",
        "radiation effects"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Tungsten"
    },
    {
      "QualifierName": [
        "radiation effects"
      ],
      "DescriptorName": "Virus Inactivation"
    }
  ]
}